Taysha Gene Therapies Announces Publication of Natural History Data for TSHA-120 in Giant Axonal Neuropathy in the Journal, BrainBusiness Wire • 06/21/21
Taysha Gene Therapies to Participate in Upcoming Investor Healthcare Conference and CEO ForumBusiness Wire • 06/15/21
Taysha Gene Therapies to Participate in Upcoming June Investor Healthcare ConferencesBusiness Wire • 05/26/21
Taysha Gene Therapies Expands Leadership Team with the Appointment of Chief Development OfficerBusiness Wire • 05/13/21
Taysha Gene Therapies to Participate in Upcoming May Investor Healthcare ConferencesBusiness Wire • 05/12/21
Taysha Gene Therapies' (TSHA) CEO RA Session II on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/11/21
Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate UpdateBusiness Wire • 05/11/21
Taysha Gene Therapies' Rett Syndrome Candidate Shows Encouraging Action In Animal Studies, Human Trial To Start By 2021Benzinga • 05/10/21
Taysha Gene Therapies Announces Publication of Preclinical Data for TSHA-102 in Rett Syndrome in Brain, a Highly Esteemed Neurological Science Peer-Reviewed JournalBusiness Wire • 05/10/21
Taysha Gene Therapies Announces Multiple Data Presentations and Workshop Presentations at the 24th Annual Meeting of the American Society of Gene & Cell TherapyBusiness Wire • 05/05/21
Taysha Gene Therapies to Release First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11Business Wire • 05/04/21
Taysha Gene Therapies Announces New Data on Multiple Preclinical Programs and Upcoming R&D DayBusiness Wire • 04/14/21
Taysha Gene Therapies Stock Is Trading Higher After Buying Rights To New Gene Therapy Candidate For Neurodegenerative DiseaseBenzinga • 04/12/21
Taysha Gene Therapies Acquires Exclusive Worldwide Rights to Clinical-Stage AAV9 Gene Therapy Program, Now Known as TSHA-120, for the Treatment of Giant Axonal Neuropathy, a Rare and Severe Neurodegenerative DiseaseBusiness Wire • 04/12/21
Taysha Gene Therapies Announces Participation in Upcoming March Investor Healthcare ConferencesBusiness Wire • 03/11/21
Taysha Gene Therapies Announces Collaboration to Advance Next-Generation Mini-Gene Payloads for an AAV Gene Therapy for the Treatment of Neurodevelopmental DisordersBusiness Wire • 03/09/21
Taysha Gene Therapies Reports Full-Year 2020 Financial Results and Provides a Corporate UpdateBusiness Wire • 03/03/21
Taysha Gene Therapies to Release Full-Year 2020 Financial Results and Host Conference Call and Webcast on March 3Business Wire • 03/01/21
Taysha Gene Therapies Announces Formation of Independent Scientific Advisory BoardBusiness Wire • 02/16/21